Bionsight, Inc.
- Biotech or pharma, therapeutic R&D
- Diagnostics
Bionsight offers a chemoproteomics-based technology that enables large-scale drug-protein interaction studies, as well as the investigation of MoA. Our platform can also be applied to target discovery, on/off-target identification and validation, and phenotypic drug development.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}